BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Koroglu M, Jacobsen KH, Demiray T, Ozbek A, Erkorkmaz U, Altindis M. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health 2017;10:513-7. [PMID: 28162965 DOI: 10.1016/j.jiph.2016.09.020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Medić S, Anastassopoulou C, Milošević V, Dragnić N, Rajčević S, Ristić M, Petrović V. Declining seroprevalence of hepatitis A in Vojvodina, Serbia. PLoS One 2019;14:e0217176. [PMID: 31163046 DOI: 10.1371/journal.pone.0217176] [Reference Citation Analysis]
2 Gecgel S, Demir C; Bursa Yuksek Ihtisas Training and Research Hospital, Departments of Infectious Diseases and Clinical Microbiology, University of Health Sciences, Yuksek Ihtisas Training and Research Hospital, Bursa, Turkey. The Effect of Vaccine Policy on HAV Seropositivity of Syrian Immigrants and Local Turkish People. JoMMID 2020;8:93-7. [DOI: 10.29252/jommid.8.3.93] [Reference Citation Analysis]
3 Jacobsen KH. Globalization and the Changing Epidemiology of Hepatitis A Virus. Cold Spring Harb Perspect Med. 2018;8. [PMID: 29500305 DOI: 10.1101/cshperspect.a031716] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
4 Patterson J, Abdullahi L, Hussey GD, Muloiwa R, Kagina BM. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis 2019;19:651. [PMID: 31331281 DOI: 10.1186/s12879-019-4235-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
5 Badur S, Öztürk S, Ozakay A, Khalaf M, Saha D, Van Damme P. A review of the experience of childhood hepatitis A vaccination in Saudi Arabia and Turkey: implications for hepatitis A control and prevention in the Middle East and North African region. Hum Vaccin Immunother 2021;17:3710-28. [PMID: 34213403 DOI: 10.1080/21645515.2021.1920871] [Reference Citation Analysis]
6 Amaruddin AI, Wahyuni S, Hamid F, Chalid MT, Yazdanbakhsh M, Sartono E. BCG scar, socioeconomic and nutritional status: a study of newborns in urban area of Makassar, Indonesia. Trop Med Int Health 2019;24:736-46. [PMID: 30884012 DOI: 10.1111/tmi.13232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Kareem N, Al-Salahat K, Bakri FG, Rayyan Y, Mahafzah A, Sallam M. Tracking the Epidemiologic Shifts in Hepatitis A Sero-Prevalence Using Age Stratification: A Cross-Sectional Study at Jordan University Hospital. Pathogens 2021;10:1081. [PMID: 34578114 DOI: 10.3390/pathogens10091081] [Reference Citation Analysis]
8 Lewin BJ, Rodriguez J, Yang SJ, Tartof SY. Predictors of hepatitis A immunity in adults in California in order to better utilize hepatitis A vaccine. Vaccine 2021;39:5484-9. [PMID: 34454784 DOI: 10.1016/j.vaccine.2021.08.056] [Reference Citation Analysis]
9 Liu CC, Lu CL, Notobroto HB, Tsai CC, Wen PH, Li CY. Individual and neighborhood socioeconomic status in the prediction of liver transplantation among patients with liver disease: A population-based cohort study in Taiwan. Medicine (Baltimore) 2019;98:e14849. [PMID: 30882681 DOI: 10.1097/MD.0000000000014849] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Gassowski M, Michaelis K, Wenzel JJ, Faber M, Figoni J, Mouna L, Friesema IH, Vennema H, Avellon A, Varela C, Sundqvist L, Lundberg Ederth J, Plunkett J, Balogun K, Ngui SL, Midgley SE, Gillesberg Lassen S, Müller L. Two concurrent outbreaks of hepatitis A highlight the risk of infection for non-immune travellers to Morocco, January to June 2018. Euro Surveill 2018;23. [PMID: 29991381 DOI: 10.2807/1560-7917.ES.2018.23.27.1800329] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
11 Badur S, Öztürk S, AbdelGhany M, Khalaf M, Lagoubi Y, Ozudogru O, Hanif K, Saha D. Hepatitis A in the Eastern Mediterranean Region: a comprehensive review. Hum Vaccin Immunother 2022;:2073146. [PMID: 35617508 DOI: 10.1080/21645515.2022.2073146] [Reference Citation Analysis]
12 Acikgoz A, Cimrin D, Kizildag S, Esen N, Balci P, Sayiner AA. Hepatitis A, B and C seropositivity among first-year healthcare students in western Turkey: a seroprevalence study. BMC Infect Dis 2020;20:529. [PMID: 32698841 DOI: 10.1186/s12879-020-05247-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Andani A, van Elten TM, Bunge EM, Marano C, Salgado F, Jacobsen KH. Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review. Expert Rev Vaccines 2020;19:795-805. [PMID: 32955965 DOI: 10.1080/14760584.2020.1813575] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Talaat M, Afifi S, Reaves EJ, Abu Elsood H, El-Gohary A, Refaey S, Hammad R, Abdel Fadeel M, Kandeel A. Evidence of sustained reductions in the relative risk of acute hepatitis B and C virus infections, and the increasing burden of hepatitis a virus infection in Egypt: comparison of sentinel acute viral hepatitis surveillance results, 2001-17. BMC Infect Dis 2019;19:159. [PMID: 30764780 DOI: 10.1186/s12879-019-3806-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Akbulut UE, Arslan E. Hepatitis A Seroprevalence in Mogadishu, Somalia. J Trop Pediatr 2022;68:fmac009. [PMID: 35134249 DOI: 10.1093/tropej/fmac009] [Reference Citation Analysis]
16 Lankarani KB, Honarvar B, Molavi Vardanjani H, Kharmandar A, Gouya MM, Zahraei SM, Baneshi MR, Ali-Akbarpour M, Kazemi M, Seif M, Fard SAZ, Emami A. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran. Vaccine 2020;38:7100-7. [PMID: 32917416 DOI: 10.1016/j.vaccine.2020.08.071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
17 Dumaidi K, Qaraqe H, Al-Jawabreh A, Abu-Helu R, Samarah F, Al-Jawabreh H. Genetic diversity, haplotype analysis, and risk factor assessment of hepatitis A virus isolates from the West Bank, Palestine during the period between 2014 and 2016. PLoS One 2020;15:e0240339. [PMID: 33306686 DOI: 10.1371/journal.pone.0240339] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Augustine SAJ, Eason TN, Simmons KJ, Griffin SM, Curioso CL, Ramudit MKD, Sams EA, Oshima KH, Dufour A, Wade TJ. Rapid Salivary IgG Antibody Screening for Hepatitis A. J Clin Microbiol 2020;58:e00358-20. [PMID: 32759356 DOI: 10.1128/JCM.00358-20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Herzog C, Van Herck K, Van Damme P. Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence. Hum Vaccin Immunother 2021;17:1496-519. [PMID: 33325760 DOI: 10.1080/21645515.2020.1819742] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Fahrni O, Posfay-Barbe KM, Wagner N. Immunization Against Hepatitis A in Migrant Children: Three Vaccination Strategies, A Retrospective Study. Pediatr Infect Dis J 2020;39:164-9. [PMID: 31929432 DOI: 10.1097/INF.0000000000002526] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]